Table 8 Levels of mRNA transcription vs outcome
From: Lymphangiogenesis and lymph node metastasis in breast cancer
| Â | ALIVE AND WELL | RECURRENCE | p-VALUE |
|---|---|---|---|
LYVE-1 | 79.1 ± 389.0 (65) | 6.1 ± 11.0 (23) | 0.932 |
PROX-1 | 4568.0 ± 6729.0 (84) | 7420.0 ± 12336 (31) | 0.076 |
Podoplanin | 13605.0 ± 78024 6550 | 9336.0 ± 15008.0 (31) | 0.186 |
5'Nuceotidase | 4230.0 ± 6550.0 (78) | 8091.0 ± 14398.0 (29) | 0.203 |
VEGFR-3 | 113.0 ± 229.0 (85) | 149.0 ± 227.0 (31) | 0.064 |
VEFG-C | 1124.0 ± 464.0 (60) | 3919.0 ± 3370.0 (22) | 0.660 |
VEGF-D | 47.9 ± 17.1(44) | 60.3 ± 24.5 (12) | 0.881 |
VEGFR-2 | 5.5 ± 15.2 (83) | 4.1 ± 99.0 (29) | 0.375 |
VEGFC:VEGF-D ratio | 148.0 ± 78.0 | 108.0 ± 106.0 | 0.77 |